EMBL alumnus transfers skills and experience to oversee starting materials for mRNA in vaccine manufacturing
Now Manager of mRNA Starting Materials at BioNTech, alumnus Pawel Masiewicz credits his experiences at EMBL with leading him to this unique professional opportunity. Credit: Justyna Masiewicz
When Pawel Masiewicz was expanding his scientific knowledge about RNA molecules at EMBL and honing his skills as a project manager, he may have hoped these experiences would land him a position at a company aspiring to individualise cancer medicine. It turned out that his hope became reality and then some, as he now works for the company that made the first approved COVID-19 vaccine.